LE WE PMID CA
Neoplasia (Carcinogenesis)14Neubildung (Karzinogenese)

14 3 3 sigma

Adiponectin

AEG1

Alcohol

Alkylanilines

Aneuploidity

Autophagy

BCL2

Bloom s syndrome

Bone marrow transplantation

Cell polarity

Cell stress (BASKET)

Centrosome

Chemoprevention

Cholic acid

Chromium

Clonorchiasis

CNS (Neoplasia)

Colon and rectum (Neoplasia)

CYP1A1

Data base (Medicine Biology Pharmacology)

Dioxin

DNA (Methylation)

DNA (Repair and Toxicology)

DNA (Replication)

Down s syndrome

Endocrine disruptor

Endotoxin

Epigenetics

Epithelio mesenchymal transition

Epithelium (BASKET)

ERS UFR (Toxikologie)

EZH2

FGF Fibroblast growth factor

Focal adhesion kinase

Friend spleen focus forming virus

GATA

Genetic instability

Genetics (Copy neutral loss of heterozygosity)

Genome toxicity

Genomic and genetic analysis

Glycemic index

Growth hormone

Helicobacter pylori

Hemopoiesis (BASKET)

Hepatitis B

Hepatitis C

Heterocyclic amines

HIF1alpha und HIF1 (BASKET)

Histone methylase

Human papilloma virus

IGF1

Interleukin11

Interleukin12

Interleukin17

Ion channel (BASKET)

Liver (Development)

Liver (Neoplasia)

Liver (Regeneration)

Lung and bronchial system (Neoplasia)

Lymphoma (Marginal zone)

Lynch syndrome

Lysophosphatidate

Maf1

Mammary gland (Neoplasia)

MDCK cells

Merotelic kinetochore attachment

Metabolic syndrome

MIF

Morphogenesis (Development)

mTORC1

Myc

Natural products

Neoplasia (Carcinogenesis)

Neoplasia (Fusion oncogenes)

Neoplasia (Imaging)

Neoplasia (Invasion and metastasis)

Neoplasia (Tumor biology and immunology)

Neutrophils

NFKB

Nickel

Obesity (BASKET)

Oxysterol

Polyamines

Polycyclic aromatic hydrocarbons

Prostate (Neoplasia)

Protein (ptm BASKET)

Radiation damage and control

Receptor (Aromatic hydrocarbon)

Retrovirus (BASKET)

Retrovirus (endogenous)

RHEB

RNA (MicroRNA)

Skin (Neoplasia Melanoma)

SMAD3

SMAD4

Soft tissues (Neoplasia)

Stem cell (Adult somatic derived reprogrammed)

Stem cell (Neoplasia)

Stem cell (Niche)

Stomach (Neoplasia)

SV40 virus

TGF beta

Toll like receptor

Tumor suppressor

Tyrosine kinase (BASKET)

Ultraviolet radiation (Toxicology)

Wnt beta Catenin TCF

1982  
1
1980  
2
Mechanisms of chemical carcinogenesis.
[7427356] Br Med J 281(6239): 529-30 (1980)
1964  
3
TUMOUR-VIRUSES AND VIRUS-TUMOURS.
[14096457] Br Med J 1(5384): 653-8 (1964)
2008  
4
Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence.
[19017178] J Intern Med 264(6): 537-48 (2008)
2006  
5
Multiple endocrine neoplasia type 1 (MEN1) as a cancer predisposition syndrome: clues into the mechanisms of MEN1-related carcinogenesis.
[17940620] Yale J Biol Med 79(3-4): 105-14 (2006)
2006  
6
Mechanisms of oncogenic cooperation in cancer initiation and metastasis.
[17940619] Yale J Biol Med 79(3-4): 95-103 (2006)
1965  
7
2006  
8
Stem cells as a two edged sword--from regeneration to tumor formation.
[17228093] J Physiol Pharmacol 57 Suppl 7(-): 5-16 (2006)
1999  
9
Development of TGF-beta resistance during malignant progression.
[10071951] Arch Pharm Res 22(1): 1-8 (1999)
2001  
10
L-Nucleoside analogues against cancer-causing viruses have potential in the prevention, delayed onset and treatment of viral associated cancers.
[11594688] Antivir Chem Chemother 12 Suppl 1(-): 5-11 (2001)
2007  
11
Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
[18025365] Arch Dermatol 143(11): 1409-12 (2007)
2008  
12
Plasticity of the cancer cell: implications for epigenetic control of melanoma and other malignancies.
[18401428] J Invest Dermatol 128(9): 2152-5 (2008)
2002  
13
Pathways to melanoma development: lessons from the mouse.
[12406321] J Invest Dermatol 119(4): 783-92 (2002)
1964  
14
FOOD-BORNE VIRUSES AND MALIGNANT HEMOPOIETIC DISEASES.
[14244727] Bacteriol Rev 28(-): 490-2 (1964)
1964  
15
VIRUS-CARCINOGEN INTERACTIONS.
[14244726] Bacteriol Rev 28(-): 480-9 (1964)
2004  
16
Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.
[15258092] Clin Microbiol Rev 17(3): 540-52, table of contents (2004)
2004  
17
Emergent human pathogen simian virus 40 and its role in cancer.
[15258090] Clin Microbiol Rev 17(3): 495-508, table of contents (2004)
2009  
18
How the study of Helicobacter infection can contribute to the understanding of carcinoma development.
[19702586] Clin Microbiol Infect 15(9): 813-22 (2009)
2004  
19
Mechanisms of human papillomavirus-induced oncogenesis.
[15479788] J Virol 78(21): 11451-60 (2004)
2009  
20
Oncoviruses and Pathogenic MicroRNAs in Humans.
[19920887] Open Virol J 3(-): 37-51 (2009)
1993  
21
Molecular basis of cancer: oncogenes and tumor suppressor genes.
[8474354] Microbiol Immunol 37(1): 11-22 (1993)
1995  
22
Leukaemogenic progression: the importance of differentiation and associated genetic events.
[7590890] Immunol Cell Biol 73(3): 193-7 (1995)
1995  
23
Model for the epigenetic mechanism of action of nongenotoxic carcinogens.
[7879735] Am J Clin Nutr 61(3 Suppl): 666S-669S (1995)
1995  
24
Methyl donors in the diet and responses to chemical carcinogens.
[7879734] Am J Clin Nutr 61(3 Suppl): 659S-665S (1995)
1991  
25
Human carcinogenesis--introductory remarks.
[1985391] Am J Clin Nutr 53(1 Suppl): 223S-225S (1991)
2008  
26
Occurrence of cancer at multiple sites: towards distinguishing multigenesis from metastasis.
[18405362] Biol Direct 3(-): 14 (2008)
2009  
27
Infectious causes of cancer and their detection.
[19678917] J Biol 8(7): 67 (2009)
2007  
28
Leukemic stem cells: from metabolic pathways and signaling to a new concept of drug resistance targeting.
[18080019] Acta Biochim Pol 54(4): 717-26 (2007)
2002  
29
Molecular basis of inherited predispositions for tumors.
[12422228] Acta Biochim Pol 49(3): 571-81 (2002)
1999  
30
Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract.
[10547029] Acta Biochim Pol 46(2): 275-87 (1999)
1999  
31
Alternative pathways of polycyclic aromatic hydrocarbons activation: the formation of polar DNA adducts.
[10547028] Acta Biochim Pol 46(2): 263-74 (1999)
1998  
32
Formation of DNA etheno adducts in rodents and humans and their role in carcinogenesis.
[9701507] Acta Biochim Pol 45(1): 145-61 (1998)
2009  
33
Ageing and cancer as diseases of epigenesis.
[19920344] J Biosci 34(4): 601-4 (2009)
2005  
34
Emergentism as a default: cancer as a problem of tissue organization.
[15824446] J Biosci 30(1): 103-18 (2005)
2010  
35
Viral-induced human carcinogenesis: an oxidative stress perspective.
[20436967] Mol Biosyst 6(7): 1162-72 (2010)
2007  
36
2007  
37
Adiponectin as a negative regulator in obesity-related mammary carcinogenesis.
[17404599] Cell Res 17(4): 280-2 (2007)
2006  
38
Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
[17016469] Cell Res 16(10): 809-17 (2006)
2005  
39
The altered DNA methylation pattern and its implications in liver cancer.
[15857582] Cell Res 15(4): 272-80 (2005)
2005  
40
Epigenetic changes in virus-associated human cancers.
[15857581] Cell Res 15(4): 262-71 (2005)
2005  
41
Epigenetic alterations in gastric carcinogenesis.
[15857579] Cell Res 15(4): 247-54 (2005)
2005  
42
The role of epigenetic inactivation of 14-3-3sigma in human cancer.
[15857578] Cell Res 15(4): 237-46 (2005)
2009  
43
Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis.
[20119532] Curr Genomics 10(5): 353-60 (2009)
2009  
44
MicroRNA Gene Networks in Oncogenesis.
[19721809] Curr Genomics 10(1): 35-41 (2009)
2009  
45
Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling.
[19721808] Curr Genomics 10(1): 26-34 (2009)
2008  
46
Genomic instability and carcinogenesis: an update.
[19516960] Curr Genomics 9(8): 535-41 (2008)
2008  
47
Cause and consequences of genetic and epigenetic alterations in human cancer.
[19506729] Curr Genomics 9(6): 394-408 (2008)
2007  
48
Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma.
[19412438] Curr Genomics 8(6): 379-97 (2007)
1995  
49
Hyper-recombination and Bloom's syndrome: microbes again provide clues about cancer.
[8808463] Genome Res 5(5): 421-6 (1995)
2007  
50
Prostate cancer epigenetics: a review on gene regulation.
[19936097] Gene Regul Syst Bio 1(-): 313-25 (2007)
2008  
51
Cancer stem cells: the theory and perspectives in cancer therapy.
[18436993] J Appl Genet 49(2): 193-9 (2008)
2008  
52
Aberrant epigenetic patterns in the etiology of gastrointestinal cancers.
[18263964] J Appl Genet 49(1): 1-10 (2008)
2006  
53
Epigenetic diagnostics of cancer--the application of DNA methylation markers.
[17132902] J Appl Genet 47(4): 365-75 (2006)
2006  
54
Mitochondrial DNA mutations in human neoplasia.
[16424612] J Appl Genet 47(1): 67-78 (2006)
2000  
55
Causality in medicine: the case of tumours and viruses.
[11205344] Philos Trans R Soc Lond B Biol Sci 355(1404): 1831-41 (2000)
1998  
56
Epithelial carcinogenesis in the mouse: correlating the genetics and the biology.
[9684281] Philos Trans R Soc Lond B Biol Sci 353(1370): 839-45 (1998)
2000  
57
Epigenetic mechanisms of the carcinogenic effects of xenobiotics and in vitro methods of their detection.
[11055794] Folia Biol (Praha) 46(5): 165-73 (2000)
1996  
58
Foulds' dangerous idea revisited: the multistep development of tumors 40 years later.
[9158937] Folia Biol (Praha) 42(6): 273-81 (1996)
2010  
59
Smad4-mediated TGF-beta signaling in tumorigenesis.
[20087440] Int J Biol Sci 6(1): 1-8 (2010)
2001  
60
DNA methylation: an alternative pathway to cancer.
[11420478] Ann Surg 234(1): 10-20 (2001)
1998  
61
Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes.
[9806178] Br J Urol 82(4): 503-12 (1998)
2004  
62
Review article: helicobacter pylori and molecular events in precancerous gastric lesions.
[15274662] Aliment Pharmacol Ther 20(3): 261-70 (2004)
1999  
63
Review article: anthranoid laxatives and their potential carcinogenic effects.
[10215727] Aliment Pharmacol Ther 13(4): 443-52 (1999)
2003  
64
Review article: molecular basis of gastric carcinogenesis.
[12786617] Aliment Pharmacol Ther 17 Suppl 2(-): 75-81 (2003)
2000  
65
Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease.
[10807417] Aliment Pharmacol Ther 14 Suppl 1(-): 153-60 (2000)
2003  
66
Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings.
[12913079] Jpn J Clin Oncol 33(6): 259-70 (2003)
2006  
67
Epimutations, inheritance and causes of aberrant DNA methylation in cancer.
[20223011] Hered Cancer Clin Pract 4(2): 75-80 (2006)
1996  
68
A general overview of the process of carcinogenesis.
[8890959] Tumori 82(4): 291-301 (1996)
1989  
69
The problem of carcinogenic hazard evaluation for new chemicals: general considerations about the carcinogenic process.
[2683274] Tumori 75(4): 299-304 (1989)
2009  
70
Breast cancer as a mitochondrial disorder (Review).
[19287978] Oncol Rep 21(4): 845-51 (2009)
1998  
71
Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review).
[9769362] Oncol Rep 5(6): 1307-18 (1998)
2010  
72
Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.
[20688584] Mol Oncol 4(5): 385-96 (2010)
2004  
73
Artificial sweeteners--do they bear a carcinogenic risk?
[15367404] Ann Oncol 15(10): 1460-5 (2004)
1988  
74
Transforming growth factor-beta: possible roles in carcinogenesis.
[3044431] Br J Cancer 57(6): 594-600 (1988)
1985  
75
Transforming ras oncogenes and multistage carcinogenesis.
[3881118] Br J Cancer 51(1): 1-7 (1985)
1977  
76
A test for mutation theory of cancer: carcinogenesis by misrepair of DNA damaged by 4-nitroquinoline 1-oxide.
[405031] Br J Cancer 35(5): 595-601 (1977)
2006  
77
Chronic inflammation: a common and important factor in the pathogenesis of neoplasia.
[16514135] CA Cancer J Clin 56(2): 69-83 (2006)
1973  
78
1970  
79
Viral etiology of cancer, leukemia and allied diseases.
[4316985] CA Cancer J Clin 20(4): 242-7 (1970)
2007  
80
Environmental pollutants and breast cancer: epidemiologic studies.
[17503436] Cancer 109(12 Suppl): 2667-711 (2007)
2007  
81
Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention.
[17503434] Cancer 109(12 Suppl): 2635-66 (2007)
2006  
82
Neoplastic stem cells: a novel therapeutic target in clinical oncology.
[17039500] Cancer 107(10): 2512-20 (2006)
2006  
83
In utero exposure to female hormones and germ cell tumors in children.
[16421921] Cancer 106(5): 1169-77 (2006)
2008  
84
Cancer as a ferrotoxic disease: are we getting hard stainless evidence?
[18612127] J Natl Cancer Inst 100(14): 976-7 (2008)
2008  
85
Regulation of telomerase and telomeres: human tumor viruses take control.
[18182620] J Natl Cancer Inst 100(2): 98-108 (2008)
2003  
86
Bacterial infections as a cause of cancer.
[12671026] J Natl Cancer Inst 95(7): E3 (2003)
2002  
87
New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer.
[12488476] J Natl Cancer Inst 94(24): 1832-6 (2002)
2000  
88
Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review.
[10841823] J Natl Cancer Inst 92(11): 874-97 (2000)
2000  
89
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
[10793105] J Natl Cancer Inst 92(9): 690-8 (2000)
1999  
90
Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice.
[10037099] J Natl Cancer Inst 91(3): 215-25 (1999)
1997  
91
Water chlorination, 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), and potential cancer risk.
[9196243] J Natl Cancer Inst 89(12): 832-3 (1997)
2008  
92
Genetic and epigenetic changes in aberrant crypt foci and serrated polyps.
[18384435] Cancer Sci 99(6): 1071-6 (2008)
2008  
93
Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells.
[18312465] Cancer Sci 99(5): 843-8 (2008)
2007  
94
Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis.
[17425590] Cancer Sci 98(4): 465-70 (2007)
2007  
95
Carcinogenesis and transcriptional regulation through Maf recognition elements.
[17129360] Cancer Sci 98(2): 135-9 (2007)
2007  
96
Multistep carcinogenesis of the colon in Apc(Min/+) mouse.
[17052257] Cancer Sci 98(1): 6-10 (2007)
2006  
97
Radiation carcinogenesis in mouse thymic lymphomas.
[16827796] Cancer Sci 97(7): 575-81 (2006)
2006  
98
Molecular mechanisms of pancreatic carcinogenesis.
[16367914] Cancer Sci 97(1): 1-7 (2006)
2005  
99
Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis.
[16367902] Cancer Sci 96(12): 835-43 (2005)
2004  
100
Genetic and epigenetic factors involved in B-cell lymphomagenesis.
[15471554] Cancer Sci 95(9): 704-10 (2004)
2004  
101
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish.
[15072585] Cancer Sci 95(4): 290-9 (2004)
2004  
102
Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1.
[14720319] Cancer Sci 95(1): 1-6 (2004)
2008  
103
The history of tumor virology.
[18829521] Cancer Res 68(19): 7693-706 (2008)
2008  
104
Advances in chemical carcinogenesis: a historical review and prospective.
[18757397] Cancer Res 68(17): 6863-72 (2008)
2008  
105
Cancers exhibit a mutator phenotype: clinical implications.
[18483233] Cancer Res 68(10): 3551-7; discussion 3557 (2008)
2007  
106
Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.
[17575120] Cancer Res 67(12): 5583-6 (2007)
2005  
107
Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting.
[16204020] Cancer Res 65(19): 8583-6 (2005)
2003  
108
A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
[12702551] Cancer Res 63(8): 1727-30 (2003)
2001  
109
The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.
[11606363] Cancer Res 61(20): 7369-74 (2001)
2001  
110
A mutator phenotype in cancer.
[11309271] Cancer Res 61(8): 3230-9 (2001)
1992  
111
A measure of genomic instability and its relevance to lymphomagenesis.
[1394170] Cancer Res 52(19 Suppl): 5545s-5546s (1992)
1992  
112
1992  
113
Pathogenetic mechanisms in B-cell non-Hodgkin's lymphomas in humans.
[1394167] Cancer Res 52(19 Suppl): 5522s-5528s (1992)
1992  
114
Workshop report from the Division of Research Grants, National Institutes of Health. Metal carcinogenesis--a Chemical Pathology Study Section Workshop.
[1617683] Cancer Res 52(14): 4058-63 (1992)
1992  
115
The origin of point mutations in human tumor cells.
[1728397] Cancer Res 52(2): 249-53 (1992)
1991  
116
Genetic errors, cell proliferation, and carcinogenesis.
[1742722] Cancer Res 51(24): 6493-505 (1991)
1991  
117
Mutator phenotype may be required for multistage carcinogenesis.
[2039987] Cancer Res 51(12): 3075-9 (1991)
1990  
118
The final common pathway of cancer.
[2199030] Cancer Res 50(16): 4830-8 (1990)
1988  
119
The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.
[3292040] Cancer Res 48(15): 4135-43 (1988)
1988  
120
Workshop report from the Division of Research Grants, National Institutes of Health. Oxy radicals in carcinogenesis--a chemical pathology study section workshop.
[3288337] Cancer Res 48(13): 3882-7 (1988)
1988  
121
Roles of cytochrome P-450 enzymes in chemical carcinogenesis and cancer chemotherapy.
[3284639] Cancer Res 48(11): 2946-54 (1988)
1988  
122
Oncogenes of DNA tumor viruses.
[3275498] Cancer Res 48(3): 493-6 (1988)
1987  
123
Recent hypotheses for the origin of colon cancer.
[3300962] Cancer Res 47(16): 4237-42 (1987)
1987  
124
Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression.
[3545445] Cancer Res 47(6): 1473-87 (1987)
1987  
125
Retroviruses as carcinogens and pathogens: expectations and reality.
[3028606] Cancer Res 47(5): 1199-220 (1987)
1987  
126
Human tissues and cells in carcinogenesis research.
[3539318] Cancer Res 47(1): 1-10 (1987)
1986  
127
Chromosome translocations and human cancer.
[3536075] Cancer Res 46(12 Pt 1): 6019-23 (1986)
1986  
128
O-alkyl pyrimidines in mutagenesis and carcinogenesis: occurrence and significance.
[3530434] Cancer Res 46(10): 4879-85 (1986)
1986  
129
Conditioned tumorigenicity of activated oncogenes.
[3011242] Cancer Res 46(7): 3211-24 (1986)
1986  
130
Mechanisms of tumor progression.
[3516380] Cancer Res 46(5): 2203-7 (1986)
1986  
131
Genetic suppression of tumor formation: a new frontier in cancer research.
[2418950] Cancer Res 46(4 Pt 1): 1573-80 (1986)
1986  
132
Role of epidermal growth factor in carcinogenesis.
[3002608] Cancer Res 46(3): 1030-7 (1986)
1986  
133
1982  
134
Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.
[6814745] Cancer Res 42(12): 4875-917 (1982)
1979  
135
Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
[383284] Cancer Res 39(9): 3289-318 (1979)
1979  
136
Alcohol-related diseases and carcinogenesis.
[221110] Cancer Res 39(7 Pt 2): 2863-86 (1979)
1978  
137
Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.
[214228] Cancer Res 38(12): 4601-9 (1978)
1978  
138
An overview of hormone-associated cancers.
[359131] Cancer Res 38(11 Pt 2): 3985-90 (1978)
1978  
139
Guanyl O6-arylamination and O6-arylation of DNA by the carcinogen N-hydroxy-1-naphthylamine.
[29702] Cancer Res 38(11 Pt 1): 3628-38 (1978)
1978  
140
Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address.
[348302] Cancer Res 38(6): 1479-96 (1978)
1978  
141
Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977).
[346205] Cancer Res 38(4): 877-85 (1978)
1977  
142
Macromolecular complexes produced by chemical carcinogens and ultraviolet radiation.
[332339] Cancer Res 37(10): 3802-14 (1977)
1977  
143
Epithelial-stromal interactions in normal and chemical carcinogen-treated adult bladder.
[332338] Cancer Res 37(10): 3720-30 (1977)
1977  
144
Prolactin and murine mammary tumorigenesis: a review.
[191183] Cancer Res 37(4): 951-63 (1977)
1976  
145
Epidermal growth control mechanisms, hyperplasia, and tumor promotion in the skin.
[179707] Cancer Res 36(7 PT 2): 2636-43 (1976)
1975  
146
Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review.
[1089044] Cancer Res 35(2): 279-86 (1975)
1974  
147
Evidence in favor of the existence of human breast cancer virus.
[4135684] Cancer Res 34(9): 2322-9 (1974)
1973  
148
Carcinogenesis--cellular evolution as a unifying thread: Presidential address.
[4594098] Cancer Res 33(11): 2537-50 (1973)
1972  
149
Cancer in man at site of prior benign lesion of skin or mucous membrane: a review.
[4555382] Cancer Res 32(7): 1359-74 (1972)
1970  
150
Chemical carcinogenesis, chemotherapy: cancer's continuing core challenges--G. H. A. Clowes Memorial Lecture.
[4917691] Cancer Res 30(6): 1549-69 (1970)
1970  
151
Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture.
[4915745] Cancer Res 30(3): 559-76 (1970)
1965  
152
A survey of the tumor virus problem from an epidemiologic standpoint.
[5320589] Cancer Res 25(8): 1277-82 (1965)
1965  
153
Natural and synthetic chemical carcinogens in the etiology of cancer.
[5320518] Cancer Res 25(8): 1292-304 (1965)
1965  
154
Multiple etiologic factors in neoplastic development.
[5320360] Cancer Res 25(8): 1339-47 (1965)
1964  
155
NEW DEVELOPMENTS IN CHEMICAL CARCINOGENESIS BY POLYCYCLIC HYDROCARBONS AND RELATED HETEROCYCLES: A REVIEW.
[14233997] Cancer Res 24(-): 1511-23 (1964)
1963  
156
THE COMPLEX ETIOLOGY OF CANCER.
[14070364] Cancer Res 23(-): 1105-15 (1963)
1962  
157
Significant biochemical effects of hepatocarcinogens in the rat: a review.
[14491168] Cancer Res 22(-): 398-430 (1962)
1960  
158
Tumor viruses and the cancer problem: a summation of the conference.
[14419106] Cancer Res 20(-): 820-9 (1960)
1956  
159
Chemical carcinogenesis as a chronic toxicity test; a review.
[13364898] Cancer Res 16(8): 728-42 (1956)
1955  
160
The significance of mutation in relation to the origin of tumors: a review.
[14379154] Cancer Res 15(4): 201-26 (1955)
1954  
161
On the etiology and pathogenesis of the leukemias: a review.
[13199794] Cancer Res 14(8): 535-48 (1954)
1954  
162
A speculative review; the probable nature of promoting action and its significance in the understanding of the mechanism of carcinogenesis.
[13190523] Cancer Res 14(7): 471-7 (1954)
1954  
163
The experimental study of tumor progression: a review.
[13160960] Cancer Res 14(5): 327-39 (1954)
1952  
164
Environmental cancers; a review.
[12988194] Cancer Res 12(10): 691-7 (1952)
1952  
165
Different types of carcinogens and their possible modes of action: a review.
[14896399] Cancer Res 12(2): 77-84 (1952)
1951  
166
The relationship between hormone-induced tissue growth and neoplasia: a review.
[14839627] Cancer Res 11(6): 393-7 (1951)
1950  
167
Chemical studies on the transformation of mouse epidermis to squamous-cell carcinoma: a review.
[15414475] Cancer Res 10(5): 255-65 (1950)
2002  
168
How DNA lesions are turned into mutations within cells?
[12483512] Oncogene 21(58): 8957-66 (2002)
2002  
169
Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis.
[12362271] Oncogene 21(45): 6884-97 (2002)
2001  
170
1998  
171
Normal development, oncogenesis and programmed cell death.
[9771961] Oncogene 17(10): 1189-94 (1998)
2004  
172
NF-kappaB: key mediator of inflammation-associated cancer.
[15611628] Cancer Biol Ther 3(12): 1214-6 (2004)
2008  
173
Mechanisms of malignant progression.
[18453542] Carcinogenesis 29(6): 1092-5 (2008)
2007  
174
A review of mechanisms of acrylamide carcinogenicity.
[17234719] Carcinogenesis 28(3): 519-28 (2007)
2006  
175
MEF immortalization to investigate the ins and outs of mutagenesis.
[16777987] Carcinogenesis 27(11): 2141-7 (2006)
2006  
176
Carcinogenesis and apoptosis: paradigms and paradoxes.
[16606631] Carcinogenesis 27(10): 1939-45 (2006)
2006  
177
Investigating human cancer etiology by DNA lesion footprinting and mutagenicity analysis.
[16344267] Carcinogenesis 27(8): 1526-37 (2006)
2006  
178
Experimental models of human bladder carcinogenesis.
[16287878] Carcinogenesis 27(3): 374-81 (2006)
2006  
179
Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection.
[16272169] Carcinogenesis 27(2): 178-96 (2006)
2006  
180
Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.
[16195239] Carcinogenesis 27(1): 1-22 (2006)
2005  
181
Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
[15975961] Carcinogenesis 26(11): 1835-45 (2005)
2005  
182
Prostate carcinogenesis and inflammation: emerging insights.
[15498784] Carcinogenesis 26(7): 1170-81 (2005)
2002  
183
Smoking-related DNA and protein adducts in human tissues.
[12507921] Carcinogenesis 23(12): 1979-2004 (2002)
2002  
184
CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
[12507920] Carcinogenesis 23(12): 1969-77 (2002)
2002  
185
The initiation of breast and prostate cancer.
[12117765] Carcinogenesis 23(7): 1095-102 (2002)
2001  
186
Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates.
[11751421] Carcinogenesis 22(12): 1903-30 (2001)
2001  
187
Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes.
[11532852] Carcinogenesis 22(9): 1335-41 (2001)
2000  
188
Threshold mechanisms and site specificity in chromium(VI) carcinogenesis.
[10753182] Carcinogenesis 21(4): 533-41 (2000)
2000  
189
Tumor progression and metastasis.
[10688870] Carcinogenesis 21(3): 497-503 (2000)
2000  
190
The role of senescence and immortalization in carcinogenesis.
[10688868] Carcinogenesis 21(3): 477-84 (2000)
2000  
191
2000  
192
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease.
[10688861] Carcinogenesis 21(3): 405-26 (2000)
2000  
193
2000  
194
Nutrition and dietary carcinogens.
[10688859] Carcinogenesis 21(3): 387-95 (2000)
2000  
195
Significance of multiple mutations in cancer.
[10688858] Carcinogenesis 21(3): 379-85 (2000)
2000  
196
Carcinogenesis in mouse and human cells: parallels and paradoxes.
[10688857] Carcinogenesis 21(3): 371-7 (2000)
2000  
197
Metabolism of chemical carcinogens.
[10688854] Carcinogenesis 21(3): 345-51 (2000)
2000  
198
Overview of carcinogenesis: past, present and future.
[10688853] Carcinogenesis 21(3): 341-4 (2000)
1999  
199
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis.
[10190547] Carcinogenesis 20(3): 353-68 (1999)
1996  
200
The role of adduct site-specific mutagenesis in understanding how carcinogen-DNA adducts cause mutations: perspective, prospects and problems.
[8640935] Carcinogenesis 17(5): 895-902 (1996)
2008  
201
Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
[17989146] Mutagenesis 23(1): 1-18 (2008)
2007  
202
Mutator pathways unleashed by epigenetic silencing in human cancer.
[17412712] Mutagenesis 22(4): 247-53 (2007)
2006  
203
Neutrophils and respiratory tract DNA damage and mutagenesis: a review.
[16870698] Mutagenesis 21(4): 225-36 (2006)
2005  
204
Do dose response thresholds exist for genotoxic alkylating agents?
[16135536] Mutagenesis 20(6): 389-98 (2005)
2005  
205
The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment.
[15784692] Mutagenesis 20(2): 81-92 (2005)
2005  
206
Review of the genotoxicity of 4-chloro-2-methylphenoxyacetic acid.
[15625068] Mutagenesis 20(1): 3-13 (2005)
2002  
207
Detection and characterization of mechanisms of action of aneugenic chemicals.
[12435848] Mutagenesis 17(6): 509-21 (2002)
2002  
208
Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine.
[12435845] Mutagenesis 17(6): 483-7 (2002)
2004  
209
Multistep tumorigenesis and the microenvironment.
[14979914] Breast Cancer Res 6(2): 93-101 (2004)
2008  
210
Oncomirs: the potential role of non-coding microRNAs in understanding cancer.
[18685719] Bioinformation 2(8): 330-4 (2008)
2006  
211
Inflammation, a key event in cancer development.
[16603636] Mol Cancer Res 4(4): 221-33 (2006)
1994  
212
Carcinogenicity of some biological agents.
[7827595] Cancer Epidemiol Biomarkers Prev 3(7): 627 (1994)
1993  
213
Methodologies for measuring carcinogen adducts in humans.
[8268781] Cancer Epidemiol Biomarkers Prev 2(6): 607-19 (1993)
2009  
214
Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium.
[20461219] Metallomics 1(3): 222-8 (2009)
2009  
215
Colorectal carcinogenesis: Review of human and experimental animal studies.
[19332896] J Carcinog 8(-): 5 (2009)
2007  
216
Viral infections as a cause of cancer (review).
[17487374] Int J Oncol 30(6): 1521-8 (2007)
2007  
217
A cell cycle hypothesis of cooperative oncogenesis (Review).
[17390006] Int J Oncol 30(5): 1051-8 (2007)
2006  
218
The tumour-Clostridium phenomenon: 50 years of developmental research (Review).
[17088987] Int J Oncol 29(6): 1479-92 (2006)
2003  
219
Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.
[12764019] Crit Rev Oral Biol Med 14(1): 47-62 (2003)
1999  
220
Proliferative and apoptotic responses in cancers with special reference to oral cancer.
[10759427] Crit Rev Oral Biol Med 10(1): 58-78 (1999)
1999  
221
Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.
[10759419] Crit Rev Oral Biol Med 10(2): 153-64 (1999)
1993  
222
Current status of histogenetic and morphogenetic concepts of salivary gland tumorigenesis.
[8292713] Crit Rev Oral Biol Med 4(5): 639-77 (1993)
1991  
223
Facts and theories concerning the mechanisms of carcinogenesis.
[1860619] FASEB J 5(9): 2280-6 (1991)
2006  
224
Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis.
[16464822] Nucleic Acids Res 34(3): 840-52 (2006)
1972  
225
Current status of chemical carcinogenesis.
[4554532] Proc Natl Acad Sci U S A 69(4): 1052-5 (1972)
1997  
226
Human cancer syndromes: clues to the origin and nature of cancer.
[9353177] Science 278(5340): 1043-50 (1997)
2008  
227
Tumor cell metabolism: cancer's Achilles' heel.
[18538731] Cancer Cell 13(6): 472-82 (2008)
2006  
228
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype.
[17097558] Cancer Cell 10(5): 355-62 (2006)
2004  
229
Crosslinks and crosstalk: human cancer syndromes and DNA repair defects.
[15607958] Cancer Cell 6(6): 539-45 (2004)
2003  
230
Defective autophagy leads to cancer.
[14706333] Cancer Cell 4(6): 422-4 (2003)
2006  
231
Connecting cancer to the asymmetric division of stem cells.
[16564003] Cell 124(6): 1121-3 (2006)
2004  
232
Principles of tumor suppression.
[14744434] Cell 116(2): 235-46 (2004)
2002  
233
Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models.
[11832205] Cell 108(2): 145-52 (2002)
2002  
234
Cancer modeling in the modern era: progress and challenges.
[11832204] Cell 108(2): 135-44 (2002)
2001  
235
Spontaneous DNA damage, genome instability, and cancer--when DNA replication escapes control.
[11239390] Cell 104(3): 329-32 (2001)
2000  
236
The hallmarks of cancer.
[10647931] Cell 100(1): 57-70 (2000)
2008  
237
The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.
[18177721] Cell Metab 7(1): 11-20 (2008)
2008  
238
Cancer: inappropriate expression of stem cell programs?
[18397746] Cell Stem Cell 2(4): 297-9 (2008)
1996  
239
Matrix metalloproteinases and the development of cancer.
[8939708] Chem Biol 3(11): 895-904 (1996)
1996  
240
Failure to unwind causes cancer. Genome stability.
[8805238] Curr Biol 6(3): 265-7 (1996)
2001  
241
How carcinogens (or telomere dysfunction) induce genetic instability: associated-selection model.
[11602239] FEBS Lett 506(3): 169-72 (2001)
2008  
242
Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis.
[18416028] Epigenetics 3(1): 1-4 (2008)
2008  
243
XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
[18285822] Eur J Hum Genet 16(6): 724-34 (2008)
2001  
244
Differentiation genes: are they primary targets for human carcinogenesis?
[11568302] Exp Biol Med (Maywood) 226(9): 805-13 (2001)
1998  
245
Hypermutability in carcinogenesis.
[9560381] Genetics 148(4): 1619-26 (1998)
1998  
246
Transient and heritable mutators in adaptive evolution in the lab and in nature.
[9560375] Genetics 148(4): 1559-66 (1998)
1998  
247
The mutation rate and cancer.
[9560368] Genetics 148(4): 1483-90 (1998)
2007  
248
Genome-epigenome interactions in cancer.
[17613554] Hum Mol Genet 16 Spec No 1(-): R96-105 (2007)
2007  
249
Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
[17613553] Hum Mol Genet 16 Spec No 1(-): R88-95 (2007)
2007  
250
Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players.
[17613548] Hum Mol Genet 16 Spec No 1(-): R60-6 (2007)
2007  
251
2007  
252
miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
[17613543] Hum Mol Genet 16 Spec No 1(-): R106-13 (2007)
2007  
253
Non-mammalian models for epigenetic analyses in cancer.
[17613542] Hum Mol Genet 16 Spec No 1(-): R1-6 (2007)
2005  
254
Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.
[15809277] Hum Mol Genet 14 Spec No 1(-): R85-92 (2005)
2005  
255
Chromatin modifying activity of leukaemia associated fusion proteins.
[15809276] Hum Mol Genet 14 Spec No 1(-): R77-84 (2005)
2005  
256
2002  
257
2001  
258
DNA helicase deficiencies associated with cancer predisposition and premature ageing disorders.
[11257107] Hum Mol Genet 10(7): 741-6 (2001)
2001  
259
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.
[11257100] Hum Mol Genet 10(7): 687-92 (2001)
2001  
260
Unraveling human cancer in the mouse: recent refinements to modeling and analysis.
[11257098] Hum Mol Genet 10(7): 669-75 (2001)
1996  
261
Mismatch repair defects in human carcinogenesis.
[8875255] Hum Mol Genet 5 Spec No(-): 1489-94 (1996)
2007  
262
IMPACTS project: preparing therapists to provide best practice early intervention services.
[17613457] Phys Occup Ther Pediatr 27(3): 73-90 (2007)
2007  
263
Murine models to evaluate novel and conventional therapeutic strategies for cancer.
[17322365] Am J Pathol 170(3): 793-804 (2007)
2006  
264
The metabolic syndrome: A high-risk state for cancer?
[17071576] Am J Pathol 169(5): 1505-22 (2006)
2000  
265
Gammaherpesviruses and "Hit-and-Run" oncogenesis.
[10623645] Am J Pathol 156(1): 1-3 (2000)
1995  
266
Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.
[7677168] Am J Pathol 147(3): 545-60 (1995)
1994  
267
Experimental production of primitive neuroectodermal tumors and its relevance to human neuro-oncology.
[8129029] Am J Pathol 144(3): 444-8 (1994)
1989  
268
Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.
[2672826] Am J Pathol 135(1): 39-61 (1989)
1983  
269
Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.
[6605691] Am J Pathol 113(2): 237-65 (1983)
1982  
270
Chemical carcinogenesis: a biologic perspective.
[7039332] Am J Pathol 106(2): 271-96 (1982)
1978  
271
Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.
[207190] Am J Pathol 91(3): 609-88 (1978)
1977  
272
Preleukemia. Cytogenetic clues in some confusing disorders.
[335894] Am J Pathol 89(2): 459-76 (1977)
1977  
273
Sequential morphologic alterations in the bronchial epithelium of Syrian golden hamsters during N-nitrosomorpholine-induced pulmonary tumorigenesis.
[20781] Am J Pathol 89(1): 59-66 (1977)
1977  
274
Carcinogenesis and aging--two related phenomena? A review.
[322509] Am J Pathol 87(2): 444-72 (1977)
1976  
275
Relationship of chromosome changes to neoplastic cell transformation.
[826168] Am J Pathol 85(3): 709-38 (1976)
1976  
276
The use of liver epithelial cultures for the study of chemical carcinogenesis.
[793415] Am J Pathol 85(3): 739-54 (1976)
1976  
277
Interaction of chemical carcinogens and drug-metabolizing enzymes in primary cultures of hepatic cells from the rat.
[11697] Am J Pathol 85(3): 755-72 (1976)
1974  
278
Are viruses important in carcinogenesis?
[4374889] Am J Pathol 77(1): 85-102 (1974)
1967  
279
Astatine-211-induced transplantatble pituitary tumor in the rat with a brief analytic review of cell types of pituitary tumors.
[6050759] Am J Pathol 51(4): 601-19 (1967)
2008  
280
Chromosomal translocations: revisited yet again.
[18779403] Blood 112(6): 2183-9 (2008)
1989  
281
Gene rearrangements and translocations in lymphoproliferative diseases.
[2653455] Blood 73(6): 1402-15 (1989)
1986  
282
Chromosomal fragile sites and cancer-specific rearrangements.
[3513870] Blood 67(4): 849-58 (1986)
1981  
283
Genetically determined susceptibility to cancer.
[7259832] Blood 58(3): 415-9 (1981)
1976  
284
Editorial: The role of cytogenetics in hematology.
[1065388] Blood 48(1): 1-7 (1976)
1967  
285
"Immunologic" oncogenesis.
[5341467] Blood 30(3): 388-94 (1967)
1959  
286
The etiology of leukemia: the status of the virus as causative agent; a review.
[13628826] Blood 14(3): 279-94 (1959)
1958  
287
Studies on submicroscopic structure of leukemias of known or suspected viral origin: a review.
[13584473] Blood 13(11): 1017-42 (1958)
1967  
288
The epidemiology of cancer in animals.
[4865378] Calif Med 107(6): 481-9 (1967)
1966  
289
Etiology of leukemia. A review.
[5327850] Calif Med 104(3): 161-5 (1966)
1965  
290
1951  
291
A review of the literature on the etiology of Hodgkin's disease.
[14801723] Calif Med 74(2): 111-4 (1951)
1984  
292
Known occupational carcinogens and their significance.
[6367918] Can Med Assoc J 130(7): 863-7 (1984)
1963  
293
1960  
294
The viral etiology of neoplasms--a review.
[13773850] Can Med Assoc J 83(-): 1049-63 (1960)
2004  
295
Genomic instability in cancer: biological and mathematical approaches.
[15254400] Cell Cycle 3(8): 1081-5 (2004)
2003  
296
Normal cells arrest cancer cells in G2.
[12963842] Cell Cycle 2(5): 454 (2003)
2003  
297
Multistep carcinogenesis: a chain reaction of aneuploidizations.
[12734426] Cell Cycle 2(3): 202-10 (2003)
2007  
298
Colorectal cancer: a model for epigenetic tumorigenesis.
[16840508] Gut 56(1): 140-8 (2007)
2006  
299
Prostaglandins and cancer.
[16118353] Gut 55(1): 115-22 (2006)
2008  
300
Molecular aspects of carcinogenesis in pancreatic cancer.
[18693168] Hepatobiliary Pancreat Dis Int 7(4): 345-56 (2008)
2001  
301
Hypercarcinogenic state in chronic liver disease.
[11506289] Intern Med 40(7): 555-6 (2001)
2008  
302
Following the cytokine signaling pathway to leukemogenesis: a chronology.
[18982163] J Clin Invest 118(11): 3564-73 (2008)
2004  
303
Aneuploidy and malignancy: an unsolved equation.
[15563660] J Clin Pathol 57(12): 1245-9 (2004)
1989  
304
A mutational theory of leukaemogenesis.
[2654188] J Clin Pathol 42(4): 337-40 (1989)
2009  
305
Radiation-induced mammary carcinogenesis in rodent models: what's different from chemical carcinogenesis?
[19506345] J Radiat Res (Tokyo) 50(4): 281-93 (2009)
2008  
306
Repair system of 7, 8-dihydro-8-oxoguanine as a defense line against carcinogenesis.
[18596371] J Radiat Res (Tokyo) 49(4): 329-40 (2008)
2006  
307
Transgenerational effects of radiation and chemicals in mice and humans.
[17019056] J Radiat Res (Tokyo) 47 Suppl B(-): B83-97 (2006)
2001  
308
Role of the Escherichia coli and human DNA glycosylases that remove 5-formyluracil from DNA in the prevention of mutations.
[11393886] J Radiat Res (Tokyo) 42(1): 11-9 (2001)
1998  
309
Cell and molecular mechanisms of pathogenesis and treatment of cancer.
[9616488] Postgrad Med J 74(868): 77-88 (1998)
1979  
310
Some aspects of the role of viruses in cancer.
[223141] Postgrad Med J 55(640): 150-8 (1979)
2008  
311
Liver is a target of arsenic carcinogenesis.
[18566022] Toxicol Sci 105(1): 24-32 (2008)
2004  
312
Evaluating the human relevance of chemically induced animal tumors.
[14737005] Toxicol Sci 78(2): 181-6 (2004)
2003  
313
Disruption of gap junctions in toxicity and carcinogenicity.
[12563100] Toxicol Sci 71(2): 146-53 (2003)
2001  
314
Alternative models for carcinogenicity testing.
[11606797] Toxicol Sci 64(1): 14-9 (2001)
1999  
315
The Single Exposure Carcinogen Database: assessing the circumstances under which a single exposure to a carcinogen can cause cancer.
[10478853] Toxicol Sci 50(2): 169-85 (1999)
2010  
316
Iron: an emerging factor in colorectal carcinogenesis.
[20135713] World J Gastroenterol 16(6): 663-72 (2010)
2009  
317
Bile acids as endogenous etiologic agents in gastrointestinal cancer.
[19610133] World J Gastroenterol 15(27): 3329-40 (2009)
2009  
318
Reactive oxygen species: a double-edged sword in oncogenesis.
[19360913] World J Gastroenterol 15(14): 1702-7 (2009)
2009  
319
Midkine translocated to nucleoli and involved in carcinogenesis.
[19152444] World J Gastroenterol 15(4): 412-6 (2009)
2008  
320
Mouse models in liver cancer research: a review of current literature.
[19058325] World J Gastroenterol 14(45): 6915-23 (2008)
2008  
321
Azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer.
[19034964] World J Gastroenterol 14(43): 6632-5 (2008)
2008  
322
Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.
[18609701] World J Gastroenterol 14(24): 3792-7 (2008)
2008  
323
Mechanisms of biliary carcinogenesis and growth.
[18494047] World J Gastroenterol 14(19): 2986-9 (2008)
2007  
324
Colorectal carcinogenesis: road maps to cancer.
[17657831] World J Gastroenterol 13(28): 3784-91 (2007)
2007  
325
Towards a multiscale model of colorectal cancer.
[17457972] World J Gastroenterol 13(9): 1399-407 (2007)
2007  
326
Hepatitis B virus-induced oncogenesis.
[17206756] World J Gastroenterol 13(1): 74-81 (2007)
2006  
327
Methylation in esophageal carcinogenesis.
[17109513] World J Gastroenterol 12(43): 6933-40 (2006)
2006  
328
Hepatic progenitor cells in human liver tumor development.
[17072946] World J Gastroenterol 12(39): 6261-5 (2006)
2006  
329
Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis.
[16718758] World J Gastroenterol 12(17): 2713-20 (2006)
2005  
330
Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis.
[16437649] World J Gastroenterol 11(45): 7063-71 (2005)
2005  
331
Multidisciplinary approach to understand the pathogenesis of gastric cancer.
[16015679] World J Gastroenterol 11(27): 4131-9 (2005)
2003  
332
Aberrant crypt foci as microscopic precursors of colorectal cancer.
[14669304] World J Gastroenterol 9(12): 2642-9 (2003)
1998  
333
Hepatocyte death in hepatocarcinogenesis.
[9657088] Hepatology 28(1): 1-5 (1998)
2006  
334
Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review).
[16465396] Int J Mol Med 17(3): 483-9 (2006)
2010  
335
Molecular oncology focus - is carcinogenesis a 'mitochondriopathy'?
[20416110] J Biomed Sci 17(-): 31 (2010)
2006  
336
Arsenic carcinogenesis in the skin.
[16807664] J Biomed Sci 13(5): 657-66 (2006)
2010  
337
Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: are we becoming victims of our own success?
[20177083] Radiology 254(3): 655-9 (2010)
2011  
338
Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.
[21473982] Am J Hum Genet 88(4): 402-21 (2011)
2010  
339
2010  
340
Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.
[20920752] Adv Genet 70(-): 277-308 (2010)
2008  
341
Environmental causes of childhood brain tumours.
[19357723] Afr Health Sci 8(1): 1-4 (2008)
2007  
342
Early S phase DNA replication: a search for targets of carcinogenesis.
[17337290] Adv Enzyme Regul 47(-): 127-38 (2007)
2011  
343
Interactions between Hsp90 and oncogenic viruses: implications for viral cancer therapeutics.
[22016826] Am J Cancer Res 1(6): 763-72 (2011)
2011  
344
Mechanisms of aneuploidy induction by RAS and RAF oncogenes.
[22016838] Am J Cancer Res 1(7): 955-71 (2011)
2011  
345
c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.
[21278493] Cancer Biol Ther 11(7): 615-26 (2011)
2004  
346
2003  
347
Chromatin remodeling and cancer.
[12673113] Cancer Biol Ther 2(1): 22-9 (2003)
2010  
348
The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.
[20728025] Adv Immunol 106(-): 93-133 (2010)
2009  
349
Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis.
[19088152] Am J Clin Nutr 89(2): 568-76 (2009)
2005  
350
The insulin-like growth factor axis: a potential link between glycemic index and cancer.
[16087968] Am J Clin Nutr 82(2): 277-8 (2005)
2010  
351
On the stem cell origin of cancer.
[20431026] Am J Pathol 176(6): 2584-494 (2010)
2005  
352
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
[15793299] Am J Pathol 166(4): 1205-16 (2005)
2007  
353
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis.
[16943240] Am J Physiol Cell Physiol 292(3): C987-95 (2007)
2004  
354
Inflammation and Cancer. I. Rodent models of infectious gastrointestinal and liver cancer.
[14766534] Am J Physiol Gastrointest Liver Physiol 286(3): G361-6 (2004)
2008  
355
Viruses associated with human cancer.
[18201576] Biochim Biophys Acta 1782(3): 127-50 (2008)
2010  
356
Hyperinsulinemia and type 2 diabetes: impact on cancer.
[20372078] Cell Cycle 9(8): 1449-50 (2010)
2004  
357
Pathways sufficient to induce epidermal carcinogenesis.
[15044848] Cell Cycle 3(5): 621-4 (2004)
2004  
358
An immunogenic process leading to cancer in the context of immunodeficiency.
[15326397] Cell Cycle 3(9): 1130-2 (2004)
2010  
359
Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis.
[20009569] Cell Cycle 9(1): 3-5 (2010)
2007  
360
An emerging role for Ca2+/calcineurin/NFAT signaling in cancerogenesis.
[17245111] Cell Cycle 6(1): 16-9 (2007)
2007  
361
Proteolysis-driven oncogenesis.
[17245132] Cell Cycle 6(2): 147-50 (2007)
2011  
362
Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.
[21274373] World J Gastroenterol 17(4): 444-8 (2011)
2010  
363
Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder.
[21086555] World J Gastroenterol 16(43): 5395-404 (2010)
2010  
364
Modifier-concept of colorectal carcinogenesis: lipidomics as a technical tool in pathway analysis.
[20397257] World J Gastroenterol 16(15): 1820-7 (2010)
2010  
365
Roles for growth factors in cancer progression.
[20430953] Physiology (Bethesda) 25(2): 85-101 (2010)
2008  
366
Inflammation and stem cells in gastrointestinal carcinogenesis.
[19074742] Physiology (Bethesda) 23(-): 350-9 (2008)
2011  
367
Morphological and molecular alterations in 1,2 dimethylhydrazine and azoxymethane induced colon carcinogenesis in rats.
[21253581] J Biomed Biotechnol 2011(-): 473964 (2011)
2011  
368
Animal models of colitis-associated carcinogenesis.
[21274454] J Biomed Biotechnol 2011(-): 342637 (2011)
2011  
369
Common fragile site tumor suppressor genes and corresponding mouse models of cancer.
[21318118] J Biomed Biotechnol 2011(-): 984505 (2011)
2011  
370
Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis.
[21127707] J Biomed Biotechnol 2011(-): 975479 (2011)
2010  
371
Liver development, regeneration, and carcinogenesis.
[20169172] J Biomed Biotechnol 2010(-): 984248 (2010)
2011  
372
Epithelial cell polarity: a major gatekeeper against cancer?
[21617693] Cell Death Differ 18(9): 1470-7 (2011)
2011  
373
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy.
[21415859] Cell Death Differ 18(9): 1414-24 (2011)
2007  
374
Ion channels in death and differentiation of prostate cancer cells.
[17479110] Cell Death Differ 14(7): 1295-304 (2007)
2008  
375
Cancer stem cells--old concepts, new insights.
[18259194] Cell Death Differ 15(6): 947-58 (2008)
2008  
376
The role of hypoxia-inducible factors in tumorigenesis.
[18259193] Cell Death Differ 15(4): 678-85 (2008)
2008  
377
The consequences of tetraploidy and aneuploidy.
[19020304] J Cell Sci 121(Pt 23): 3859-66 (2008)
2010  
378
The possible role of IL-17 in obesity-associated cancer.
[21103795] ScientificWorldJournal 10(-): 2265-71 (2010)
2009  
379
Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.
[19075184] Endocr Rev 30(1): 51-74 (2009)
2010  
380
New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases.
[20581310] Blood 116(14): 2429-37 (2010)
2008  
381
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.
[18948588] Blood 112(9): 3543-53 (2008)
2010  
382
Targeting the translational machinery as a novel treatment strategy for hematologic malignancies.
[20075156] Blood 115(11): 2127-35 (2010)
2010  
383
Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies.
[20107230] Blood 115(14): 2731-9 (2010)
2009  
384
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.
[19139078] Blood 113(12): 2619-28 (2009)
2011  
385
Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system.
[21459792] Haematologica 96(7): 1041-8 (2011)
2009  
386
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.
[19608670] Haematologica 94(8): 1109-23 (2009)
2011  
387
MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
[22031668] Discov Med 12(65): 307-17 (2011)
2010  
388
Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis.
[20515613] Discov Med 9(48): 448-54 (2010)
2009  
389
Deregulation of cell death (apoptosis): implications for tumor development.
[19788869] Discov Med 8(41): 61-3 (2009)
2010  
390
Role of innate immunity in Helicobacter pylori-induced gastric malignancy.
[20664074] Physiol Rev 90(3): 831-58 (2010)
2006  
391
Interruption of cell transformation and cancer formation.
[17077297] FASEB J 20(13): 2209-13 (2006)
2007  
392
The role of pre-replicative complex (pre-RC) components in oncogenesis.
[17690155] FASEB J 21(14): 3786-94 (2007)
2008  
393
Carcinogenesis induced by foreign bodies.
[18707584] Biochemistry (Mosc) 73(7): 763-75 (2008)
2008  
394
Tissue-specific transcription factors in progression of epithelial tumors.
[18605982] Biochemistry (Mosc) 73(5): 573-91 (2008)
2008  
395
Genetic polymorphism and variability of chemical carcinogenesis.
[18605979] Biochemistry (Mosc) 73(5): 543-54 (2008)
2008  
396
Reorganization of molecular morphology of epitheliocytes and connective-tissue cells in morphogenesis and carcinogenesis.
[18605977] Biochemistry (Mosc) 73(5): 528-31 (2008)
2008  
397
2008  
398
Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis.
[18605975] Biochemistry (Mosc) 73(5): 504-13 (2008)
2008  
399
On the path to understanding the nature of cancer.
[18605973] Biochemistry (Mosc) 73(5): 487-97 (2008)
2007  
400
Control of the autophagy maturation step by the MAPK ERK and p38: lessons from environmental carcinogens.
[17102581] Autophagy 3(1): 57-9 (2007)
2010  
401
Role of cell cycle regulators in lung carcinogenesis.
[20139697] Cell Adh Migr 4(1): 114-23 (2010)
2010  
402
Lung cancer: a modified epigenome.
[20139698] Cell Adh Migr 4(1): 107-13 (2010)
2009  
403
The role of focal adhesion kinase in tumor initiation and progression.
[19690467] Cell Adh Migr 3(4): 347-50 (2009)
2010  
404
Inflammation and oncogenesis: a vicious connection.
[20036794] Curr Opin Genet Dev 20(1): 65-71 (2010)
2010  
405
Cancer models in Caenorhabditis elegans.
[20175192] Dev Dyn 239(5): 1413-48 (2010)
2010  
406
Dysregulation of the mevalonate pathway promotes transformation.
[20696928] Proc Natl Acad Sci U S A 107(34): 15051-6 (2010)
2003  
407
The two faces of transforming growth factor beta in carcinogenesis.
[12861075] Proc Natl Acad Sci U S A 100(15): 8621-3 (2003)
2010  
408
2011  
409
Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.
[21994739] Viruses 3(4): 398-422 (2011)
2010  
410
Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice.
[21994618] Viruses 2(10): 2235-57 (2010)
2010  
411
2009  
412
The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors.
[19326434] Cancer 115(10): 2031-40 (2009)
2010  
413
Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.
[20388784] Cancer Res 70(8): 3287-98 (2010)
2004  
414
Modern criteria to establish human cancer etiology.
[15289363] Cancer Res 64(15): 5518-24 (2004)
2009  
415
Developmental origins of cancer.
[19654290] Cancer Res 69(16): 6375-7 (2009)
2008  
416
Genetic instability is not a requirement for tumor development.
[18483234] Cancer Res 68(10): 3558-60; discussion 3560-1 (2008)
2009  
417
Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.
[19903854] Cancer Res 69(22): 8529-35 (2009)
2010  
418
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
[20234370] Br J Cancer 102(6): 941-6 (2010)
2009  
419
The mysterious steps in carcinogenesis.
[19638985] Br J Cancer 101(3): 379-80 (2009)
2009  
420
Molecular origins of cancer: Molecular basis of colorectal cancer.
[20018966] N Engl J Med 361(25): 2449-60 (2009)
2008  
421
Molecular origins of cancer.
[18234758] N Engl J Med 358(5): 527 (2008)
2008  
422
2010  
423
Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.
[20373871] Future Oncol 6(4): 587-603 (2010)
2009  
424
Role of prolonged mitotic checkpoint activation in the formation and treatment of cancer.
[19903065] Future Oncol 5(9): 1363-70 (2009)
2002  
425
Molecular mechanisms in nickel carcinogenesis: modeling Ni(II) binding site in histone H4.
[12426119] Environ Health Perspect 110 Suppl 5(-): 719-23 (2002)
2004  
426
The science and practice of carcinogen identification and evaluation.
[15345338] Environ Health Perspect 112(13): 1269-74 (2004)
2005  
427
Age-related differences in susceptibility to carcinogenesis. II. Approaches for application and uncertainty analyses for individual genetically acting carcinogens.
[15811844] Environ Health Perspect 113(4): 509-16 (2005)
2005  
428
Ascorbate depletion: a critical step in nickel carcinogenesis?
[15866766] Environ Health Perspect 113(5): 577-84 (2005)
2006  
429
Carcinogen-modified DNA and specific humoral immunity toward carcinogen-DNA adducts. A review.
[17033140] Ann Ist Super Sanita 42(2): 189-94 (2006)
2006  
430
Molecular mechanisms of carcinogenesis by vinyl chloride.
[17033136] Ann Ist Super Sanita 42(2): 163-9 (2006)
2006  
431
Genotoxicity and carcinogenicity of acrylamide: a critical review.
[17033134] Ann Ist Super Sanita 42(2): 144-55 (2006)
2006  
432
Development of carcinogenicity classifications and evaluations: the case of formaldehyde.
[17033133] Ann Ist Super Sanita 42(2): 132-43 (2006)
2006  
433
Towards a harmonized approach for risk assessment of genotoxic carcinogens in the European Union.
[17033132] Ann Ist Super Sanita 42(2): 127-31 (2006)
2006  
434
Structure-activity models of chemical carcinogens: state of the art, and new directions.
[17033131] Ann Ist Super Sanita 42(2): 118-26 (2006)
2006  
435
Role of experimental and epidemiological evidence of carcinogenicity in the primary prevention of cancer.
[17033130] Ann Ist Super Sanita 42(2): 113-7 (2006)
2008  
436
A novel approach: chemical relational databases, and the role of the ISSCAN database on assessing chemical carcinogenicity.
[18469376] Ann Ist Super Sanita 44(1): 48-56 (2008)
2008  
437
The ISS Carcinogens Data Bank (BDC).
[18469374] Ann Ist Super Sanita 44(1): 31-42 (2008)
2010  
438
Toll-like receptors, tissue injury, and tumourigenesis.
[20871832] Mediators Inflamm 2010(-): - (2010)
2010  
439
A new view of carcinogenesis and an alternative approach to cancer therapy.
[20062820] Mol Med 16(3-4): 144-53 (2010)
2003  
440
Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis.
[14608108] J Nutr 133(11 Suppl 1): 3740S-3747S (2003)
2007  
441
UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents.
[17382466] Cancer Lett 255(1): 1-11 (2007)
2006  
442
Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.
[16154258] Cancer Lett 239(2): 157-67 (2006)
2010  
443
DNA replication fidelity and cancer.
[20951805] Semin Cancer Biol 20(5): 281-93 (2010)
2008  
444
Theories of carcinogenesis: an emerging perspective.
[18472276] Semin Cancer Biol 18(5): 372-7 (2008)
2010  
445
Merotelic attachments and non-homologous end joining are the basis of chromosomal instability.
[20478024] Cell Div 5(-): 13 (2010)
2010  
446
The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth.
[20106901] Carcinogenesis 31(8): 1319-28 (2010)
2010  
447
Models of carcinogenesis: an overview.
[20430846] Carcinogenesis 31(10): 1703-9 (2010)
2010  
448
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.
[19955394] Carcinogenesis 31(1): 37-49 (2010)
2010  
449
Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research.
[19969554] Carcinogenesis 31(1): 83-9 (2010)
2010  
450
Monocyclic aromatic amines as potential human carcinogens: old is new again.
[19887514] Carcinogenesis 31(1): 50-8 (2010)
2010  
451
Basic properties and molecular mechanisms of exogenous chemical carcinogens.
[19858070] Carcinogenesis 31(2): 135-48 (2010)
2009  
452
Base excision repair of oxidative DNA damage and association with cancer and aging.
[18978338] Carcinogenesis 30(1): 2-10 (2009)
2008  
453
Context-dependent regulation of cutaneous immunological responses by TGFbeta1 and its role in skin carcinogenesis.
[17893229] Carcinogenesis 29(1): 9-14 (2008)
2006  
454
Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.
[16690811] Endocrinology 147(6 Suppl): S18-24 (2006)
2011  
455
Novel insights on imaging sex-hormone-dependent tumourigenesis in vivo.
[21367845] Endocr Relat Cancer 18(3): R41-51 (2011)
2010  
456
MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.
[19843580] Endocr Relat Cancer 17(1): F51-75 (2010)
2008  
457
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.
[21677822] Clin Exp Gastroenterol 1(): 19-47 (2008)
2011  
458
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications.
[21609503] BMC Med 9(-): 63 (2011)
2010  
459
Chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on NTP carcinogenesis bioassays.
[20019352] Toxicol Pathol 38(1): 188-97 (2010)
2010  
460
Precancer: sequentially acquired or predetermined?
[20019354] Toxicol Pathol 38(1): 171-9 (2010)
2010  
461
Oxidative stress and oxidative damage in carcinogenesis.
[20019356] Toxicol Pathol 38(1): 96-109 (2010)
2007  
462
Overview of the molecular carcinogenesis of mouse lung tumor models of human lung cancer.
[17325975] Toxicol Pathol 35(1): 75-80 (2007)
2009  
463
Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?
[19100242] Biochem Pharmacol 77(4): 681-8 (2009)
2010  
464
Leukaemogenesis: more than mutant genes.
[20029422] Nat Rev Cancer 10(1): 23-36 (2010)
2007  
465
2002  
466
Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.
[11923879] Cad Saude Publica 18(2): 357-77 (2002)
2011  
467
On the missing link between inflammation and cancer.
[21272501] Dermatol Online J 17(1): 10 (2011)
2002  
468
Molecular aspects of hepatic carcinogenesis.
[11896411] Rev Inst Med Trop Sao Paulo 44(1): 39-48 (2002)
2011  
469
NNK-Induced Lung Tumors: A Review of Animal Model.
[21559252] J Oncol 2011(-): 635379 (2011)
2011  
470
Epigenetic effects and molecular mechanisms of tumorigenesis induced by cigarette smoke: an overview.
[21559255] J Oncol 2011(-): 654931 (2011)
2011  
471
Oral carcinogenesis and oral cancer chemoprevention: a review.
[21660266] Patholog Res Int 2011(-): 431246 (2011)
2011  
472
Malignancies in autoimmune rheumatic diseases - a mini-review.
[20453490] Gerontology 57(1): 3-10 (2011)
2011  
473
Heterogeneity of the tumorigenic phenotype expressed by Madin-Darby canine kidney cells.
[21819694] Comp Med 61(3): 243-50 (2011)
2010  
474
A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.
[20603725] Curr Oncol Rep 12(5): 314-8 (2010)
2009  
475
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
[19531241] BMC Cancer 9(-): 187 (2009)
2011  
476
Environment and cancer: the legacy of Lorenzo Tomatis.
[21489205] Environ Health 10 Suppl 1(-): S1 (2011)
2010  
477
The tumor microenvironment in colorectal carcinogenesis.
[21209781] Cancer Microenviron 3(1): 149-66 (2010)
2002  
478
Molecular and genetic mechanisms of lymphomagenesis.
[12402389] Croat Med J 43(5): 519-25 (2002)
2009  
479
Autoimmunity and lymphomagenesis.
[19089924] Int J Cancer 124(7): 1497-502 (2009)
2007  
480
Carcinogenic food contaminants.
[17530489] Cancer Invest 25(3): 189-96 (2007)
2008  
481
Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway.
[18606007] Int Arch Med 1(1): 10 (2008)
2011  
482
Exploring the molecular mechanisms of nickel-induced genotoxicity and carcinogenicity: a literature review.
[21905451] Rev Environ Health 26(2): 81-92 (2011)
2010  
483
Endotoxin exposure and lung cancer risk: a systematic review and meta-analysis of the published literature on agriculture and cotton textile workers.
[20012774] Cancer Causes Control 21(4): 523-55 (2010)
2009  
484
Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.
[19892662] Cancer Prev Res (Phila) 2(11): 922-30 (2009)
2008  
485
2008  
486
Liver stem cells and tgf-Beta in hepatic carcinogenesis.
[19343145] Gastrointest Cancer Res 2(4 Suppl): S27-30 (2008)
2002  
487
Genetic mechanisms of hepatocarcinogenesis.
[11971194] Oncogene 21(16): 2593-604 (2002)
2010  
488
2009  
489
Biology of urothelial tumorigenesis: insights from genetically engineered mice.
[20012171] Cancer Metastasis Rev 28(3-4): 281-90 (2009)
2011  
490
A continuum model for tumour suppression.
[21833082] Nature 476(7359): 163-9 (2011)
2003  
491
2007  
492
Epigenetic field for cancerization.
[17394762] J Biochem Mol Biol 40(2): 142-50 (2007)
2011  
493
The link between the metabolic syndrome and cancer.
[21912508] Int J Biol Sci 7(7): 1003-15 (2011)
2011  
494
A clinical overview of centrosome amplification in human cancers.
[22043171] Int J Biol Sci 7(8): 1122-44 (2011)
2010  
495
Origin of chromosomal translocations in lymphoid cancer.
[20371343] Cell 141(1): 27-38 (2010)
2007  
496
Roles of Smad3 in TGF-beta signaling during carcinogenesis.
[17725494] Crit Rev Eukaryot Gene Expr 17(4): 281-93 (2007)
2011  
497
Mechanisms of oxysterol-induced carcinogenesis.
[21388551] Lipids Health Dis 10(-): 44 (2011)
2008  
498
Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents.
[17879298] Environ Mol Mutagen 49(1): 9-15 (2008)
2010  
499
Oncoprotein metastasis and its suppression revisited.
[20380702] J Exp Clin Cancer Res 29(-): 30 (2010)
2010  
500
Chronic bacterial and parasitic infections and cancer: a review.
[20539059] J Infect Dev Ctries 4(5): 267-81 (2010)
2011  
501
Tumorigenesis related to retroviral infections.
[22112727] J Infect Dev Ctries 5(11): 751-8 (2011)
2009  
502
Mutational spectra of human cancer.
[19308457] Hum Genet 125(5-6): 493-506 (2009)
2002  
503
Choline deficiency associated with diethanolamine carcinogenicity.
[11961209] Toxicol Sci 67(1): 1-3 (2002)
2007  
504
Clinical implications and utility of field cancerization.
[17362521] Cancer Cell Int 7(-): 2 (2007)
2003  
505
Bulky DNA adducts and risk of cancer: a meta-analysis.
[12582026] Cancer Epidemiol Biomarkers Prev 12(2): 157-60 (2003)
2008  
506
Protein damage by reactive electrophiles: targets and consequences.
[18052106] Chem Res Toxicol 21(1): 117-28 (2008)
2008  
507
Potential mechanisms of estrogen quinone carcinogenesis.
[18052105] Chem Res Toxicol 21(1): 93-101 (2008)
2008  
508
Progress and challenges in selected areas of tobacco carcinogenesis.
[18052103] Chem Res Toxicol 21(1): 160-71 (2008)
2008  
509
Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.
[17970581] Chem Res Toxicol 21(1): 28-44 (2008)
2008  
510
Mitochondrial concept of leukemogenesis: key role of oxygen-peroxide effects.
[19014456] Theor Biol Med Model 5(-): 23 (2008)
2007  
511
Does the immune reaction cause malignant transformation by disrupting cell-to-cell or cell-to-matrix communications?
[17480231] Theor Biol Med Model 4(-): 16 (2007)
2007  
512
Polyamines and nonmelanoma skin cancer.
[17234230] Toxicol Appl Pharmacol 224(3): 249-56 (2007)
2007  
513
Interleukin-12 and photocarcinogenesis.
[17239911] Toxicol Appl Pharmacol 224(3): 220-7 (2007)
2007  
514
Immunohistochemical markers of cancerogenesis in the lung.
[17597018] Folia Histochem Cytobiol 45(2): 65-74 (2007)
2010  
515
Roles of fibroblast growth factor receptors in carcinogenesis.
[21047773] Mol Cancer Res 8(11): 1439-52 (2010)
2009  
516
The links between transcription, beta-catenin/JNK signaling, and carcinogenesis.
[19671687] Mol Cancer Res 7(8): 1189-96 (2009)
2010  
517
NF-kappaB and cancer: how intimate is this relationship.
[19823771] Mol Cell Biochem 336(1-2): 25-37 (2010)
2006  
518
2006  
519
2010  
520
GATA Transcription Factors and Cancer.
[21779441] Genes Cancer 1(12): 1178-88 (2010)
2010  
521
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.
[21152115] Int J Biol Sci 6(7): 730-55 (2010)
2010  
522
More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer.
[20610798] J Leukoc Biol 88(6): 1109-17 (2010)
2010  
523
Stromal mediation of radiation carcinogenesis.
[21181431] J Mammary Gland Biol Neoplasia 15(4): 381-7 (2010)
2011  
524
2011  
525
Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment.
[21163908] Toxicol Sci 120 Suppl 1(): S130-45 (2011)
2010  
526
Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis.
[21154999] World J Gastroenterol 16(46): 5790-800 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Neubildung (Karzinogenese)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia